
### [NCIT:C121974](http://purl.obolibrary.org/obo/NCIT_C121974)
**Label:** Ph-Like Acute Lymphoblastic Leukemia

**Subclasses:** [NCIT:C134835](http://purl.obolibrary.org/obo/NCIT_C134835) (Refractory Ph-Like Acute Lymphoblastic Leukemia), [NCIT:C134834](http://purl.obolibrary.org/obo/NCIT_C134834) (Recurrent Ph-Like Acute Lymphoblastic Leukemia), 

**Class expressions from DL-Learner:**

- [NCIT:C38343](http://purl.obolibrary.org/obo/NCIT_C38343) (JAK-STAT Pathway Deregulation) 58.33%
- [NCIT:C38328](http://purl.obolibrary.org/obo/NCIT_C38328) (Unfavorable Clinical Outcome) 58.33%
- [NCIT:C129969](http://purl.obolibrary.org/obo/NCIT_C129969) (CRLF2 Gene Rearrangement) 58.33%
- [NCIT:C128844](http://purl.obolibrary.org/obo/NCIT_C128844) (Philadelphia Chromosome Negative) 58.33%
- [NCIT:C128834](http://purl.obolibrary.org/obo/NCIT_C128834) (BCR/ABL1 Fusion Negative) 58.33%
- Thing 51.59%
- [NCIT:C36715](http://purl.obolibrary.org/obo/NCIT_C36715) (BCR-ABL1 Fusion Protein Expression) 33.33%
- [NCIT:C36341](http://purl.obolibrary.org/obo/NCIT_C36341) (Signal Transduction Pathway Deregulation) 33.33%
- [NCIT:C3910](http://purl.obolibrary.org/obo/NCIT_C3910) (Molecular Abnormality) 28.83%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 27.35%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) 25.00%
- [NCIT:C36327](http://purl.obolibrary.org/obo/NCIT_C36327) (Gene Abnormality) 22.50%
- [NCIT:C36391](http://purl.obolibrary.org/obo/NCIT_C36391) (Molecular Genetic Variation) 21.81%
- [NCIT:C97926](http://purl.obolibrary.org/obo/NCIT_C97926) (Molecular Sequence Variation) 21.67%
- [NCIT:C133155](http://purl.obolibrary.org/obo/NCIT_C133155) (Gene Rearrangement Abnormality) 18.14%


